Seminars in Nephrology
Volume 24, Issue 4 , Pages 316-323 , July 2004

NO bioavailability, endothelial dysfunction, and acute renal failure: new insights into pathophysiology

  • Michael S Goligorsky

      Affiliations

    • Department of Medicine, New York Medical College, Valhalla, NY, USA
    • Department of Pharmacology, New York Medical College, Valhalla, NY, USA
    • Corresponding Author InformationAddress reprint requests to Michael S. Goligorsky, MD, PhD, Division of Nephrology and Renal Research Institute, New York Medical College, Basic Sciences Building, Valhalla, NY 10595 USA
    • ,
  • Sergey V Brodsky

      Affiliations

    • Department of Medicine, New York Medical College, Valhalla, NY, USA
    • ,
  • Eisei Noiri

      Affiliations

    • Department of Medicine, The University of Tokyo, Tokyo, Japan

References 

  1. Lee L, Meyer T, Pollock AS. Endothelial cell injury initiates glomerular sclerosis in the remnant kidney. J Clin Invest. 1995;96:953–964
  2. Johnson RJ. What mediates progressive glomerulosclerosis? The glomerular endothelium comes of age. Am J Pathol. 1997;151:1179–1181
  3. Shimizu A, Kitamura H, Masuda Y. Rare glomerular capillary regeneration and subsequent capillary regression with endothelial cell apoptosis in progressive glomerulonephritis. Am J Pathol. 1997;151:1231–1239
  4. Basile DP, Donohoe D, Roethe K, et al.  Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol. 2001;281:F887–F899
  5. Goligorsky MS, Brodsky SV, Noiri E. Nitric oxide in acute renal failure (NOS versus NOS). Kidney Int. 2002;61:855–861
  6. Brodsky SV, Yamamoto T, Tada T, et al.  Endothelial dysfunction in ischemic acute renal failure (Rescue by transplanted endothelial cells). Am J Physiol. 2002;282:F1140–F1149
  7. Tsukahara H, Gordienko D, Goligorsky MS. Continuous monitoring of NO release by endothelial cells. Biochem Biophys Res Commun. 1993;193:722–729
  8. Kim Y-M, Tzeng E, Billiar TR. Role of NO and nitrogen intermediates in regulation of cell functions. In:  Goligorsky MS,  Gross SS editor. Nitric Oxide and the Kidney. New York: Chapman & Hall; 1997;p. 22–51
  9. Davis K, Martin E, Turko I, et al.  Novel effects of NO. Annu Rev Pharmacol Toxicol. 2001;41:203–236
  10. Yu L, Gengaro P, Niederberger M, et al.  Nitric oxide (A mediator in rat tubular hypoxia/reoxygenation injury). Proc Natl Acad Sci U S A. 1994;91:1691–1695
  11. Peresleni T, Noiri E, Bahou WF, et al.  Antisense oligodeoxynucleotides to inducible NO synthase rescue epithelial cells from oxidative stress injury. Am J Physiol. 1996;270:F971–F977
  12. Lafon-Cazal M, Pietri S, Culcasi M, et al.  NMDA-dependent superoxide production and neurotoxicity. Nature. 1993;364:535–537
  13. Lipton SA, Choi Y-B, Pan Z-H, et al.  A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 1993;364:626–632
  14. Radi R, Beckman J, Bush K, et al.  Peroxinitrite-induced membrane lipid peroxidation (The cytotoxic potential of superoxide and nitric oxide). Arch Biochem Biophys. 1991;288:481–487
  15. Morita K, Ihnken K, Buckberg GD, et al.  Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts. J Clin Invest. 1994;93:2658–2666
  16. Malinsky T, Bailey F, Zhang Z, et al.  NO measured by a porphyrinic microsensor in rat brain after transient middle cerebral occlusion. J Cereb Blood Flow Metab. 1993;13:355–358
  17. Ling H, Gengaro PE, Edelstein CL, et al.  Effect of hypoxia on proximal tubules isolated from nitric oxide synthase knockout mice. Kidney Int. 1998;53:1642–1646
  18. Noiri E, Peresleni T, Miller F, et al.  Antisense oligonucleotides to the inducible NOS prevent tubular cell death in ischemic acute renal failure. J Clin Invest. 1996;97:2377–2383
  19. Noiri E, Nakao A, Uchida K, et al.  Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol. 2001;281:48–57
  20. Masumoto H, Kissner R, Koppenol W, et al.  Kinetic study of the reaction of ebselen with peroxynitrite. FEBS Lett. 1996;398:179–182
  21. Bian K, Davis K, Kuret J, et al.  Nitrotyrosine formation with endotoxin-induced renal injury detected by immunohistochemistry. Am J Physiol. 1999;277:F33–F40
  22. Zou M-H, Ullrich V. Peroxynitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine aortic prostacyclin synthase. FEBS Lett. 1996;382:101–104
  23. Goodwin DC, Landino LM, Marnett LJ. Effects of nitric oxide and nitric oxide-derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis. FASEB J. 1999;13:1121–1143
  24. MacMillan-Crow LA, Crow J, Kerby J, et al.  Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci U S A. 1996;93:11853–11858
  25. Beckman JS, Beckman TW, Chen J, et al.  Apparent hydroxyl radical production by peroxynitrite (Implications for endothelial injury from nitric oxide and superoxide). Proc Natl Acad Sci U S A. 1990;87:1620–1624
  26. Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo?. FEBS Lett. 1997;411:157–160
  27. Xia Y, Zweier JL. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci U S A. 1997;94:6954–6958
  28. Conger JD, Robinette J, Guggenheim S. Effect of acetylcholine on the early phase of norepinephrine-induced acute renal failure. Kidney Int. 1981;19:399–409
  29. Conger J, Robinette J, Villar A, et al.  Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats. J Clin Invest. 1995;96:631–638
  30. Flores J, DiBona D, Beck C, et al.  The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. J Clin Invest. 1972;51:118–126
  31. Summers W, Jamison RL. The no-reflow phenomenon in renal ischemia. Lab Invest. 1971;25:635–643
  32. Leaf A. Cell swelling (A factor in ischemic tissue injury). Circulation. 1973;48:455–458
  33. Lieberthal W, Wolf E, Rennke HG, et al.  Renal ischemia and reperfusion impair endothelium-dependent vascular relaxation. Am J Physiol. 1989;256:F894–F900
  34. Kelly K, Williams W, Colvin B, et al.  Antibody to intercellular adhesion molecule-1 protects the kidney against ischemic injury. Proc Natl Acad Sci U S A. 1994;91:812–817
  35. Romanov V, Noiri E, Czerwinski G, et al.  Two novel probes reveal tubular and vascular RGD binding sites in the ischemic rat kidney. Kidney Int. 1997;52:93–102
  36. Furchgott RF, Zawadzki JW. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373–376
  37. Goligorsky MS, Menton D, Laszlo A, et al.  Nature of thrombin-induced sustained elevation in cytosolic calcium concentration in cultured endothelial cells. J Biol Chem. 1989;264:16771–16775
  38. McDonald DM. Endothelial gaps and permeability of venules in rat tracheas exposed to inflammatory stimuli. Am J Physiol. 1994;266:L61–L83
  39. Boubier C, Gaynor E, Cintron J, et al.  Circulating endothelium as an indication of vascular injury. Thrombos Diathes Haemorrh. 1970;40(suppl):163–167
  40. Hladovec J, Rossmann P. Circulating endothelial cells isolated together with platelets and the experimental modification of their counts in rats. Thrombos Res. 1973;3:665–674
  41. Solovey A, Lin Y, Browne P, et al.  Circulating activated endothelial cells in sickle cell anemia. N Engl J Med. 1997;337:1584–1590
  42. Asahara T, Murohara T, Sullivan A, et al.  Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–967
  43. Shi Q, Rafii S, Wu M, et al.  Evidence for circulating bone marrow-derived endothelial cells. Blood. 1998;92:362–367
  44. Rafii S. Circulating endothelial precursors (Mystery, reality, and promise). J Clin Invest. 2000;105:17–19
  45. Asahara T, Masuda H, Takahashi T, et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221–228
  46. Kalka C, Masuda H, Takahashi T, et al.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovasacularization. Proc Natl Acad Sci U S A. 2000;97:3422–3427
  47. Kawamoto A, Gwon HC, Iwaguro H, et al.  Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation. 2001;103:634–637
  48. Schatteman G, Hanlon H, Jiao C, et al.  Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest. 2000;106:571–578
  49. Crosby J, Kaminski W, Schatteman G, et al.  Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res. 2000;87:728–730
  50. Takahashi T, Kalka C, Masuda H, et al.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999;5:434–438
  51. Vasa M, Fichtlscherer S, Aicher A, et al.  Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:e1–e7
  52. Peichev M, Naiyer A, Pereira D, et al.  Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood. 2000;95:952–958
  53. Christensen J, Weissman I. Flk-2 is a marker in hematopoietic stem cell differentiation (A simple method to isolate long-term stem cells). Proc Natl Acad Sci U S A. 2001;98:14541–14546

☆ Supported in part by National Institutes of Health grants DK52783, DK45462, and DK45659 (M.S.G.), and an American Heart Association Fellowship 0120200T (S.V.B.).

PII: S0270-9295(04)00051-8

doi: 10.1016/j.semnephrol.2004.04.003

Seminars in Nephrology
Volume 24, Issue 4 , Pages 316-323 , July 2004

Article Tools

* Image Usage & Resolution